A bonus episode featuring a conversation with top executives at Johnson & Johnson Diabetes Care Companies (parent company of Animas). John Wilson is the Worldwide Vice President, Insulin Delivery and Krishna Venugopalan is the Worldwide Director, Research & Development, Insulin Delivery. They talk to Stacey about the significance of this approval, about Animas’s agreement with Dexcom and what’s coming next as that company moves forward with the Share, G5 and G6 versions of their CGM. 

Find out more about Moms’ Night Out 

Please visit our Sponsors & Partners – they help make the show possible!

Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com)

Omnipod – Simplify Life

Learn about Dexcom 

Edgepark Medical Supplies

Check out VIVI Cap to protect your insulin from extreme temperatures

Learn more about AG1 from Athletic Greens 

Drive research that matters through the T1D Exchange

The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:

Sign up for our newsletter here

Here’s where to find us:

Facebook (Group)

Facebook (Page)

Instagram

Twitter

Check out Stacey’s books!

Learn more about everything at our home page www.diabetes-connections.com 

Reach out with questions or comments: info@diabetes-connections.com